aTyr Pharma | 8-K: aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 2 16:08 ET
aTyr Pharma | DEFA14A: Others
Apr 5 16:05 ET
aTyr Pharma | DEF 14A: Definitive information statements
Apr 5 16:04 ET
aTyr Pharma | 8-K: aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Mar 14 16:06 ET
aTyr Pharma | S-3: Registration statement for specified transactions by certain issuers
Nov 9, 2023 17:01 ET
aTyr Pharma | 8-K: aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
Nov 9, 2023 16:06 ET
aTyr Pharma | 8-K: Current report
Sep 26, 2023 09:01 ET
aTyr Pharma | 8-K: Current report
Sep 11, 2023 08:04 ET
aTyr Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 10, 2023 16:07 ET
aTyr Pharma | 8-K: aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
Aug 9, 2023 16:10 ET
aTyr Pharma | 8-K: Current report
May 19, 2023 16:17 ET
aTyr Pharma | 8-K: aTyr Pharma Announces First Quarter 2023 Results and Provides Corporate Update
May 9, 2023 16:07 ET
aTyr Pharma | DEFA14A: Others
Mar 29, 2023 16:19 ET
aTyr Pharma | DEFA14A: Others
Mar 29, 2023 16:17 ET
aTyr Pharma | DEF 14A: Definitive proxy statements
Mar 29, 2023 16:12 ET
aTyr Pharma | 8-K: Current report
Mar 10, 2023 17:01 ET
aTyr Pharma | 8-K: aTyr Pharma Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
Mar 9, 2023 16:03 ET
aTyr Pharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Mar 7, 2023 21:16 ET
aTyr Pharma | 8-K: Current report
Feb 9, 2023 16:48 ET
aTyr Pharma | 8-K: Current report
Feb 6, 2023 08:03 ET
No Data
No Data